| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date | Match? |
|---|
| External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry | [1]Paula Jimenez-Fonseca, [2]Alberto Carmona-Bayonas, [3]Alba Martinez-Torron, [4]Maria Alsina, [5]Ana Custodio, [6]Olbia Serra, [7]Diego Cacho Lavin, [8]María Luisa Limón, [9]Tamara Sauri, [10]Flora López, ..., [24]Federico Longo, [25]Avinash Ramchandani, [26]Marta Martín Richard, [27]Alicia Hurtado, [28]Aitor Azkarate, ... [Full author list] | Therapeutic advances in medical oncology [missing] | DOI: 10.1177/17588359211019672 [ORCID]
PubMed: 34211587 [ORCID]
| | 2021-06-17 | |
| External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit? | [1]Paula Fonseca, [2]Alberto Carmona-Bayonas, [3]Eva Martínez de Castro, [4]Ana Custodio, [5]Carles Pericay Pijaume, [6]Raquel Hernandez, [7]Gema Aguado, [8]Natalia Castro Unanua, [9]Juana María Cano, [10]Flora López, ..., [24]Alfonso Martín Carnicero, [25]Monserrat Mangas, [26]Marta Martín Richard, [27]Mónica Granja, [28]Avinash Ramchandani, ... [Full author list] | Gastric Cancer [missing] | DOI: 10.1007/S10120-020-01116-X [ORCID]
PubMed: 32970266 [ORCID]
| docetaxel [missing] | 2020-09-24 | |
| Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study | [1]Ruth Vera, [2]María Luisa Gómez, [3]Juan Ramón Ayuso, [4]Joan Figueras, [5]Pilar García-Alfonso, [6]Virginia Martínez, [7]Adelaida Lacasta, [8]Ana Ruiz-Casado, [9]María José Safont, [10]Jorge Aparicio, [11]Juan Manuel Campos, [12]Juan Carlos Cámara, [13]Marta Martín-Richard, [14]Clara Montagut, [15]Carles Pericay, ... [Full author list] | Cancers [missing] | DOI: 10.3390/CANCERS12082259 [ORCID]
PubMed: 32806731 [ORCID]
| colorectal cancer [missing] | 2020-08-12 | |
| Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry | [1]Almudena Cotes Sanchís, [2]Javier Gallego, [3]Raquel Hernandez, [4]Virginia Arrazubi, [5]Ana Custodio, [6]Juana María Cano, [7]Gema Aguado, [8]Ismael Macias, [9]Carlos Lopez, [10]Flora López, ..., [21]Alfonso Martín Carnicero, [22]Mónica Granja, [23]Marta Martín Richard, [24]Carolina Hernández Pérez, [25]Alicia Hurtado, ... [Full author list] | PLOS One [missing] | DOI: 10.1371/JOURNAL.PONE.0235848 [ORCID]
PubMed: 32735623 [ORCID]
| | 2020-07-31 | |
| VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02) | [1]Jaime Feliu, [2]Rocio Garcia-Carbonero, [3]Jaume Capdevila, [4]Inmaculada Guasch, [5]Vicente Alonso-Orduna, [6]Carlos Lopez, [7]Pilar Garcia-Alfonso, [8]Carmen Castanon, [9]Isabel Sevilla, [10]Laura Cerezo, [11]Carles Conill, [12]Begona Quintana-Angel, [13]Maria E Sanchez, [14]Ismael Ghanem, [15]Marta Martin-Richard, [16]Miriam Lopez-Gomez, [17]Ana Leon, [18]Monica Caro, [19]Teresa Fernandez, [20]Joan Maurel [Full author list] | Cancer Medicine [missing] | DOI: 10.1002/CAM4.2722 [ORCID]
PubMed: 31851776 [ORCID]
| fluorouracil [missing] | 2019-12-18 | |
| Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial | [1]Carlos Fernández-Martos, [2]Carles Pericay, [3]Ferran Losa, [4]Rocio García-Carbonero, [5]Laura Layos, [6]Nuria Rodríguez-Salas, [7]Marta Martin-Richard, [8]Vicente Alonso-Orduña, [9]Ruth Vera, [10]Javier Gallego, [11]Jaume Capdevila, [12]Antonieta Salud, [13]Miquel Nogué, [14]Joan Maurel, [15]Inmaculada Guash, [16]Clara Montagut, [17]Carlos Lopez, [18]Ismael Macias, [19]Rakesh K Jain, [20]Xabier Garcia-Albeniz [Full author list] | JAMA Oncology [missing] | DOI: 10.1001/JAMAONCOL.2019.2294 [ORCID]
PubMed: 31465088 [ORCID]
| aflibercept [missing] | 2019-08-29 | |
| Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer | [1]Alberto Carmona-Bayonas, [2]Paula Jimenez-Fonseca, [3]Marcelo Garrido, [4]Ana Custodio, [5]Raquel Hernandez, [6]Alejandra Lacalle, [7]Juana María Cano, [8]Gema Aguado, [9]Eva Martínez de Castro, [10]Felipe Alvarez Manceñido, [11]Ismael Macias, [12]Laura Visa, [13]Marta Martín Richard, [14]Monserrat Mangas, [15]Manuel Sánchez Cánovas, ... [Full author list] | Thrombosis and Haemostasis [missing] | DOI: 10.1055/S-0039-1694012 [ORCID]
PubMed: 31461750 [ORCID]
| | 2019-08-28 | |
| Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial) | [1]Joan Maurel, [2]Santiago Sánchez Cabús, [3]Berta Laquente, [4]Lydia Gaba, [5]Laura Visa, [6]Joan Fabregat, [7]Ignacio Povés, [8]Susana Roselló, [9]Roberto Díaz-Beveridge, [10]Marta Martín-Richard, [11]Javier Rodriguez, [12]Luis Sabater, ... [Full author list] | Cancer Chemotherapy and Pharmacology [missing] | DOI: 10.1007/S00280-018-3682-9 [ORCID]
PubMed: 30225601 [ORCID]
| pancreatic cancer [missing] | 2018-09-17 | |
| Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients | [1]Vicente Alonso, [2]Pilar Escudero, [3]Carlos Fernández-Martos, [4]Antonia Salud, [5]Miguel Méndez, [6]Javier Gallego, [7]Jose-R Rodriguez, [8]Marta Martín-Richard, [9]Julen Fernández-Plana, [10]Hermini Manzano, [11]José-Carlos Méndez, [12]Monserrat Zanui, [13]Esther Falcó, [14]Mireia Gil-Raga, [15]Federico Rojo, [16]Miriam Cuatrecasas, [17]Jaime Feliu, [18]Xabier García-Albéniz, [19]Joan Maurel [Full author list] | Neoplasia [missing] | DOI: 10.1016/J.NEO.2018.05.004 [ORCID]
PubMed: 29842993 [ORCID]
| colorectal cancer [missing]; cetuximab [missing]; metastatic colon cancer [missing] | 2018-05-26 | |
| Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer | [1]Jordi Codony-Servat, [2]Miriam Cuatrecasas, [3]Elena Asensio, [4]Carla Montironi, [5]Anna Martínez-Cardús, [6]Mercedes Marín-Aguilera, [7]Carlos Horndler, [8]Eva Martínez-Balibrea, [9]Michele Rubini, [10]Pedro Jares, ..., [12]Iván Victoria, [13]Lydia Gaba, [14]Marta Martín-Richard, [15]Vicente Alonso, [16]Pilar Escudero, ... [Full author list] | British Journal of Cancer [missing] | DOI: 10.1038/BJC.2017.279 [ORCID]
PubMed: 29123263 [ORCID]
| colorectal cancer [missing] | 2017-11-09 | |
| [Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma]. | [1]Marta Martin-Richard, [2]Angels Ginès, [3]Juan Ramón Ayuso, [4]Luis Sabater, [5]Joan Fabregat, [6]Ramiro Mendez, [7]Gloria Fernández-Esparrach, [8]Xavier Molero, [9]Eva C Vaquero, [10]Miriam Cuatrecasas, [11]Antonio Ferrández, [12]Joan Maurel, [13]Comité multidisciplinar para la actualización de las recomendaciones para el manejo de las lesiones pre-malignas y el adenocarcinoma de páncreas [Full author list] | Medicina clínica [missing] | DOI: 10.1016/J.MEDCLI.2016.07.033 [ORCID]
PubMed: 27726847 [ORCID]
| | 2016-10-07 | |
| Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients | [1]Miguel Caballero-Baños, [2]Daniel Benitez-Ribas, [3]Jaime Tabera, [4]Sara Varea, [5]Ramon Vilana, [6]Luis Bianchi, [7]Juan Ramón Ayuso, [8]Mario Pagés, [9]Gemma Carrera, [10]Miriam Cuatrecasas, [11]Marta Martin-Richard, [12]Joan Cid, [13]Miquel Lozano, [14]Antoni Castells, [15]Xabier García-Albéniz, [16]Joan Maurel, [17]Ramon Vilella [Full author list] | European Journal of Cancer [missing] | DOI: 10.1016/J.EJCA.2016.06.008 [ORCID]
PubMed: 27428073 [ORCID]
| colorectal cancer [missing]; dendritic cell [missing]; colorectal carcinoma [missing]; phase II clinical trial [missing] | 2016-07-15 | |
| Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study | [1]Marta Martín-Richard, [2]Bartomeu Massutí, [3]Eva Pineda, [4]Vicente Alonso, [5]Maribel Marmol, [6]Daniel Castellano, [7]Emilio Fonseca, [8]Antonio Galán, [9]Marta Llanos, [10]Maria Angeles Sala, [11]Carlos Pericay, [12]Fernando Rivera, [13]Javier Sastre, [14]Angel Segura, [15]Maria Quindós, [16]Pascal Maisonobe, [17]TTD (Tumores del Tracto Digestivo) Study Group [Full author list] | BMC Cancer [missing] | DOI: 10.1186/1471-2407-13-427 [ORCID]
PubMed: 24053191 [ORCID]
| multicenter clinical trial [missing] | 2013-09-20 | |
| Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer | [0]Josep Maria Auge Fradera, [1]Joan Maurel, [2]Marta Martin-Richard, [3]Carlos Conill, [4]Marcelo Sánchez, [5]Lourdes Petriz, [6]Angels Ginès, [7]Rosa Miquel, [8]Rosa Gallego, [9]Rosana Cajal, [10]Carmen Ayuso, [11]Salvador Navarro, [12]Maribel Marmol, [13]Cristina Nadal, [14]Josep Maria Augé, [15]Laureano Fernández-Cruz, [16]Pere Gascón [Full author list] | International Journal of Radiation Oncology Biology Physics [missing] | DOI: 10.1016/J.IJROBP.2006.07.008 [ORCID]
PubMed: 16965868 [ORCID]
| pancreatic cancer [missing]; phase I clinical trial [missing] | 2006-09-11 | |
| FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer | [1]Cristina Nadal, [2]Joan Maurel, [3]Rosa Gallego, [4]Antoni Castells, [5]Raquel Longarón, [6]Maribel Marmol, [7]Sergi Sanz, [8]Rafael Molina, [9]Marta Martin-Richard, [10]Pere Gascón [Full author list] | Clinical Cancer Research [missing] | DOI: 10.1158/1078-0432.CCR-04-2119 [ORCID]
PubMed: 16000573 [ORCID]
| colorectal cancer [missing]; oxaliplatin [missing] | 2005-07-01 | |
| Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma | [1]Joan Maurel, [2]Andrés Cervantes, [3]Carlos Conill, [4]Ramón Salazar, [5]Marta Martin-Richard, [6]Manuel Pera, [7]Hermini Manzano, [8]Isabel Chirivella, [9]Rosa Gallego, [10]Xavier Marfa [Full author list] | International Journal of Radiation Oncology Biology Physics [missing] | DOI: 10.1016/J.IJROBP.2004.09.009 [ORCID]
PubMed: 15850907 [ORCID]
| fluorouracil [missing]; oxaliplatin [missing]; phase I clinical trial [missing] | 2005-05-01 | |